Back to search
FDAFDA · Food and drugs·Recall number D-0393-2022

Metoprolol Succinate Extended-Release Tablets, USP, 25 mg, Rx Only, 100 Tablets per bottle, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013, India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ, 07054, NDC 67877-590-01.

Published February 2, 2022 · Recall initiated: January 12, 2022

Summary

FDA records drug Class II recall D-0393-2022, published February 2, 2022 and initiated January 12, 2022. Recalling firm: Ascend Laboratories, LLC; Status: Terminated; Reported quantity: 9216 bottles; Lot: Lot #: 21143093, Exp. March 2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications.

What to do

Voluntary: Firm initiated · Letter

Get an email if METOPROLOL SUCCINATE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
METOPROLOL SUCCINATE
Manufacturer
Ascend Laboratories, LLC
Distributor
Nationwide in the USA
Lot
Lot #: 21143093, Exp. March 2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Metoprolol Succinate Extended-Release Tablets, USP, 25 mg, Rx Only, 100 Tablets per bottle, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013, India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ, 07054, NDC 67877-590-01. recalled?

Yes. FDA published recall D-0393-2022 on February 2, 2022. Reported hazard: Failed Dissolution Specifications.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: METOPROLOL SUCCINATE.